IMCR · Immunocore Holdings plc
$34.21
+0.01 (+0.03%)
At close · Aug 14
Market Cap
$1.76B
Shares
51.50M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding IMCR
73 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Fidelity Growth Company Fund | — | 1,121,692 | $32,405,682 | 0.03% | Long | 2026-05-31 | |
| PRIMECAP Odyssey Aggressive Growth Fund | — | 1,112,800 | $31,058,248 | 0.46% | Long | 2026-04-30 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 643,368 | $19,397,545 | 0.18% | Long | 2026-03-31 | |
| Select Health Care Portfolio | — | 500,000 | $14,445,000 | 0.25% | Long | 2026-05-31 | |
| T. Rowe Price Small-Cap Stock Fund, Inc. | — | 465,030 | $14,020,655 | 0.17% | Long | 2026-03-31 | |
| Fidelity Growth Company K6 Fund | — | 330,328 | $9,543,176 | 0.03% | Long | 2026-05-31 | |
| T. Rowe Price Small-Cap Value Fund, Inc. | — | 296,284 | $8,932,963 | 0.10% | Long | 2026-03-31 | |
| MFS New Discovery Fund | — | 304,295 | $8,791,083 | 0.41% | Long | 2026-05-31 | |
| iShares Biotechnology ETF | — | 277,185 | $8,357,128 | 0.10% | Long | 2026-03-31 | |
| Select Biotechnology Portfolio | — | 287,200 | $8,297,208 | 0.16% | Long | 2026-05-31 | |
| T. Rowe Price Institutional Small-Cap Stock Fund | — | 264,520 | $7,975,278 | 0.18% | Long | 2026-03-31 | |
| Fidelity Series Growth Company Fund | — | 261,570 | $7,556,757 | 0.03% | Long | 2026-05-31 | |
| Fidelity Advisor Health Care Fund | — | 260,000 | $7,256,600 | 0.25% | Long | 2026-04-30 | |
| SmallCap Fund | — | 227,200 | $6,341,152 | 0.30% | Long | 2026-04-30 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 188,691 | $5,451,283 | 0.09% | Long | 2026-05-29 | |
| Fidelity Capital Appreciation Fund | — | 158,900 | $4,434,899 | 0.06% | Long | 2026-04-30 | |
| MFS New Discovery Series | — | 102,016 | $3,075,782 | 0.43% | Long | 2026-03-31 | |
| THE HARTFORD HEALTHCARE FUND | — | 108,668 | $3,032,924 | 0.42% | Long | 2026-04-30 | |
| VIP Health Care Portfolio | — | 84,000 | $2,532,600 | 0.25% | Long | 2026-03-31 | |
| abrdn Healthcare Investors | HQH | 66,916 | $2,017,517 | 0.18% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) Portfolio Developed World ex-US ETF | — | 63,806 | $1,923,751 | 0.01% | Long | 2026-03-31 | |
| HUSSMAN STRATEGIC MARKET CYCLE FUND | — | 60,000 | $1,809,000 | 0.46% | Long | 2026-03-31 | |
| ALPS Medical Breakthroughs ETF | — | 52,254 | $1,509,618 | 0.93% | Long | 2026-05-31 | |
| abrdn Life Sciences Investors | HQL | 49,941 | $1,505,721 | 0.27% | Long | 2026-03-31 | |
| NYLI Fiera SMID Growth Fund | — | 53,781 | $1,501,028 | 0.65% | Long | 2026-04-30 | |
| T. Rowe Price Health Sciences Portfolio | — | 39,016 | $1,176,332 | 0.18% | Long | 2026-03-31 | |
| BlackRock Health Sciences Term Trust | BMEZ | 37,226 | $1,122,364 | 0.11% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF | — | 33,934 | $1,023,110 | 0.13% | Long | 2026-03-31 | |
| Steward Values Enhanced International Fund | — | 35,726 | $997,113 | 0.33% | Long | 2026-04-30 | |
| Old Westbury Small & Mid Cap Strategies Fund | — | 35,496 | $990,693 | 0.01% | Long | 2026-04-30 | |
| Tema Oncology ETF | — | 30,849 | $891,228 | 0.51% | Long | 2026-05-31 | |
| Large-Cap Growth Portfolio | — | 25,652 | $814,451 | 0.06% | Long | 2026-06-30 | |
| Small Cap Value Portfolio | — | 26,553 | $800,573 | 0.14% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 26,042 | $752,353 | 0.00% | Long | 2026-05-31 | |
| Virtus Biotech Etf | — | 25,714 | $717,678 | 1.21% | Long | 2026-04-30 | |
| VOYA MULTI-MANAGER INTERNATIONAL SMALL CAP FUND | — | 22,848 | $637,688 | 0.11% | Long | 2026-04-30 | |
| SmallCap Account | — | 20,500 | $618,075 | 0.36% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index ETF | — | 19,801 | $572,051 | 0.01% | Long | 2026-05-31 | |
| BlackRock Health Sciences Trust | BME | 16,565 | $499,435 | 0.09% | Long | 2026-03-31 | |
| Health Sciences Trust | — | 16,454 | $496,088 | 0.22% | Long | 2026-03-31 | |
| iShares International Small-Cap Equity Factor ETF | — | 16,731 | $466,962 | 0.07% | Long | 2026-04-30 | |
| Nationwide International Small Cap Fund | — | 16,642 | $464,478 | 0.16% | Long | 2026-04-30 | |
| 1290 VT Micro Cap Portfolio | — | 13,700 | $413,055 | 0.24% | Long | 2026-03-31 | |
| HARTFORD HEALTHCARE HLS FUND | — | 12,125 | $365,569 | 0.35% | Long | 2026-03-31 | |
| Health Sciences Portfolio | — | 11,435 | $363,061 | 0.10% | Long | 2026-06-30 | |
| EQ/T.Rowe Price Health Sciences Portfolio | — | 11,527 | $347,539 | 0.22% | Long | 2026-03-31 | |
| Archer Growth ETF | — | 10,806 | $312,185 | 2.42% | Long | 2026-05-31 | |
| Amplify Treatments, Testing and Advancements ETF | AIEQ | 9,166 | $310,636 | 3.36% | Long | 2024-06-30 | |
| International Opportunities Fund | — | 7,949 | $229,647 | 0.08% | Long | 2026-05-31 | |
| Empower Small Cap Growth Fund | — | 5,912 | $178,247 | 0.08% | Long | 2026-03-31 |
Showing 1–50 of 73 positions
Key facts
CIK
1671927
CUSIP
45258D105
13F (30d)
135 filings
127 filers
Visit website
Investor relations